Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Nexchip Semiconductor  / Equity Capital Markets

<ul>
<li>Nexchip has passed its HKEX hearing for an A+H listing. CICC is the sole sponsor.</li>
<li>We look at the company's core segments: display driver ICs, image sensors, and power management ICs.</li>
<li>We discussed our preliminary thoughts on the company's fair value based on A-H premium.</li>
</ul>


Nexchip has passed its HKEX hearing for an A+H listing. CICC is the sole sponsor.
We look at the company's core segments: display driver ICs, image sensors, and power management ICs.
We discussed our preliminary thoughts on the company's fair value based on A-H premium.


TSMC (Taiwan Semiconductor Manufacturing) (2330 TT)

TSMC (Taiwan Semiconductor Manufacturing)

SMIC (Semiconductor Manufacturing International Corp) (981 HK)

SMIC (Semiconductor Manufacturing International Corp)

SMIC (Semiconductor Manufacturing International Corp) (688981 CH)

Smartsens Technology (Shanghai) (688213 CH)

Nexchip (晶合集成) A+H Pre-IPO: Early Thoughts